Abstract:Three series of novel heterocyclic azoles derivatives containing pyrazine (5a-5k, 8a-8k and 11a-11k) have been designed, synthesized, structurally determined, and their biological activities were evaluated as potential telomerase inhibitors. Among the oxadiazole derivatives, compound 5c showed the most potent biological activity against SW1116 cancer cell line (IC(50)=2.46 μM against SW1116 and IC(50)=3.55 μM for telomerase). Compound 8h performed the best in the thiadiazole derivatives (IC(50)=0.78 μM against HEPG2 and IC(50)=1.24 μM for telomerase), which was comparable to the positive control. While compound 11f showed the most potent biological activity (IC(50)=4.12 μM against SW1116 and IC(50)=15.03 μM for telomerase) among the triazole derivatives. Docking simulation by positioning compounds 5c, 8h and 11f into the telomerase structure active site was performed to explore the possible binding model. The results of apoptosis demonstrated that compound 8h possessed good antitumor activity against HEPG2 cancer cell line. Therefore, compound 8h with potent inhibitory activity in tumor growth inhibition may be a potential antitumor agent against HEPG2 cancer cell. Therefore, the introduction of oxadiazole, thiadiazole and triazole structures reinforced the combination of our compounds and the receptor, resulting in progress of bioactivity.

Design and Synthesis of Novel 5-Phenyl-n-piperidine Ethanone Containing 4,5-Dihydropyrazole Derivatives As Potential Antitumor Agents.

Design and Synthesis of N-phenylacetyl (sulfonyl) 4,5-Dihydropyrazole Derivatives As Potential Antitumor Agents.

Novel Coumarin-Dihydropyrazole Thio-Ethanone Derivatives: Design, Synthesis and Anticancer Activity.

Design and Synthesis of Novel 2-Methyl-4,5-substitutedbenzo[f]-3,3a,4,5-tetrahydro-pyrazolo[1,5-d][1,4]oxazepin-8(7h)-one Derivatives As Telomerase Inhibitors

Synthesis and Molecular Docking Study of Novel Coumarin Derivatives Containing 4,5-Dihydropyrazole Moiety As Potential Antitumor Agents

Synthesis, Molecular Modeling and Biological Evaluation of N-benzylidene-2-((5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl)thio)acetohydrazide Derivatives As Potential Anticancer Agents

Synthesis, Biological Evaluation, 3D-QSAR Studies of Novel Aryl-2H-pyrazole Derivatives As Telomerase Inhibitors.

Synthesis and Molecular Docking Studies of Novel 2-Chloro-pyridine Derivatives Containing Flavone Moieties As Potential Antitumor Agents.

Design, Synthesis and Biological Evaluation of Heterocyclic Azoles Derivatives Containing Pyrazine Moiety As Potential Telomerase Inhibitors

4,5-Dihydropyrazole derivatives containing oxygen-bearing heterocycles as potential telomerase inhibitors with anticancer activity

Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents.

Synthesis, biological evaluation, and molecular docking studies of pyrazolyl-acylhydrazone derivatives as novel anticancer agents

Synthesis and Biological Evaluation of Quinoline–imidazole Hybrids As Potent Telomerase Inhibitors: a Promising Class of Antitumor Agents

Synthesis, Molecular Modeling and Biological Evaluation of 2-Aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3h)-thione Quinolone Derivatives As Novel Anticancer Agent

Novel 3-(1-acetyl-5-(substituted-phenyl)-4,5-dihydro-1h-pyrazol-3-yl)-7-fluoro-2h-chromen-2-one Derivatives: Synthesis and Anticancer Activity

Synthesis and Biological Evaluation of Novel Pyrazoline Derivatives Containing Indole Skeleton As Anti-Cancer Agents Targeting Topoisomerase II.

Design, Synthesis, and Biological Evaluation of Novel 4‐phenoxypyridine Derivatives As Potential Antitumor Agents

Benzophenone-nucleoside Derivatives As Telomerase Inhibitors: Design, Synthesis and Anticancer Evaluation in Vitro and in Vivo.

Design, synthesis and SARs of novel telomerase inhibitors based on BIBR1532

Novel 3-(2-(3-methyl-5-substituted-phenyl-4,5-dihydropyrazol-1-yl)-2-oxoethoxy)-2-substituted-phenyl-4H-chromen-4-one: synthesis and anticancer activity.

Design, synthesis, and biological evaluation of novel thieno[3,2-<i>d</i>]pyrimidine derivatives as potent antitumor agents